8.00
Schlusskurs vom Vortag:
$8.85
Offen:
$8.85
24-Stunden-Volumen:
11.07M
Relative Volume:
1.66
Marktkapitalisierung:
$1.41B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-6.7227
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-11.21%
1M Leistung:
+6.81%
6M Leistung:
+10.50%
1J Leistung:
-15.70%
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TDOC
Teladoc Health Inc
|
8.00 | 1.56B | 2.54B | -207.36M | 151.25M | -1.19 |
![]()
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-25 | Eingeleitet | Mizuho | Neutral |
2024-11-15 | Eingeleitet | Goldman | Buy |
2024-09-17 | Bestätigt | Jefferies | Hold |
2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
2024-01-03 | Eingeleitet | Barclays | Overweight |
2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | Eingeleitet | Truist | Hold |
2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
2022-08-12 | Eingeleitet | DA Davidson | Buy |
2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
2022-07-28 | Herabstufung | Needham | Buy → Hold |
2022-07-06 | Bestätigt | BofA Securities | Neutral |
2022-05-05 | Herabstufung | Argus | Buy → Hold |
2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
2022-04-07 | Eingeleitet | Guggenheim | Buy |
2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
2022-03-03 | Hochstufung | Argus | Hold → Buy |
2022-02-23 | Bestätigt | BofA Securities | Neutral |
2022-02-23 | Bestätigt | Craig Hallum | Hold |
2022-02-23 | Bestätigt | Evercore ISI | In-line |
2022-02-23 | Bestätigt | Goldman | Buy |
2022-02-23 | Bestätigt | JP Morgan | Overweight |
2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
2022-02-23 | Bestätigt | Needham | Buy |
2022-02-23 | Bestätigt | Oppenheimer | Outperform |
2022-02-23 | Bestätigt | Stifel | Hold |
2022-02-11 | Eingeleitet | Goldman | Buy |
2022-02-08 | Bestätigt | Piper Sandler | Overweight |
2021-12-02 | Fortgesetzt | Jefferies | Hold |
2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
2021-10-28 | Bestätigt | Barclays | Equal Weight |
2021-10-28 | Bestätigt | BofA Securities | Neutral |
2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
2021-10-28 | Bestätigt | Citigroup | Buy |
2021-10-28 | Bestätigt | Craig Hallum | Hold |
2021-10-28 | Bestätigt | Needham | Buy |
2021-10-28 | Bestätigt | Oppenheimer | Outperform |
2021-10-28 | Bestätigt | Piper Sandler | Overweight |
2021-10-28 | Bestätigt | UBS | Neutral |
2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
2021-08-02 | Herabstufung | Argus | Buy → Hold |
2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
2021-04-15 | Eingeleitet | Needham | Buy |
2021-01-07 | Eingeleitet | BTIG Research | Buy |
2020-12-22 | Eingeleitet | Evercore ISI | In-line |
2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
2020-12-04 | Eingeleitet | Goldman | Neutral |
2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2020-09-22 | Eingeleitet | DA Davidson | Buy |
2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
2020-07-14 | Eingeleitet | Citigroup | Buy |
2020-07-13 | Eingeleitet | Argus | Buy |
2020-07-07 | Eingeleitet | Stephens | Overweight |
2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-01-10 | Eingeleitet | UBS | Neutral |
2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
3 Medical Service Industry Stocks Poised to Counter Workforce Issues - Yahoo Finance
Tick level data insight on Teladoc Health Inc. volatilityJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
Will Teladoc Health Inc. see short term momentumMarket Risk Report & Real-Time Buy Signal Alerts - newser.com
Analyzing Teladoc Health Inc. with risk reward ratio chartsDip Buying & Free Weekly Watchlist of Top Performers - newser.com
Visualizing Teladoc Health Inc. stock with heatmapsBond Market & Long-Term Growth Portfolio Plans - newser.com
Why Teladoc Health Inc. stock could see breakout soonMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Telehealth Services Market Accelerating Remote Healthcare Delivery - openPR.com
Historical volatility pattern of Teladoc Health Inc. visualizedEarnings Risk Summary & Reliable Trade Execution Plans - newser.com
Why Teladoc Health Inc. (4LL) stock stays on top picksTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
How interest rate cuts could boost Teladoc Health Inc. stockPortfolio Risk Report & Reliable Entry Point Trade Alerts - newser.com
Is Teladoc Health Inc. stock attractive for ETFsQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Technical signs of recovery in Teladoc Health Inc.Product Launch & Safe Entry Trade Signal Reports - newser.com
Institutional scanner results for Teladoc Health Inc.July 2025 Patterns & Entry and Exit Point Strategies - newser.com
Applying chart zones and confluence areas to Teladoc Health Inc.2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Will breakout in Teladoc Health Inc. lead to full recoveryTrade Performance Summary & Risk Controlled Swing Alerts - newser.com
Is Teladoc Health Inc. building a consolidation base2025 Historical Comparison & Reliable Trade Execution Plans - newser.com
What valuation ratios show for Teladoc Health Inc. (4LL) stockJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Teladoc Health Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Evercore ISI Group Maintains Teladoc Health (TDOC) In-Line Recommendation - Nasdaq
Why Is Teladoc (TDOC) Stock Soaring Today - TradingView
TDOC: Evercore ISI Group Raises Price Target for Teladoc Health - GuruFocus
Best Telemedicine Services That Connect You With Doctors Right Away - CNET
United States Virtual Care Market: 13.2%+ CAGR to US$ 72.73 - openPR.com
United States Telemedicine Market 2025 | Industry Developments, Future Growth, Share & Industry Insights - openPR.com
What drives Teladoc Health Inc stock priceEx-Dividend Date Alerts & Minimal Capital Investment - earlytimes.in
Online Marketplace Stocks Q2 In Review: Teladoc (NYSE:TDOC) Vs Peers - TradingView
Teladoc and Uber Stocks Trade Down, What You Need To Know - The Globe and Mail
Teladoc Health (TDOC): Assessing Valuation After Recent Share Price Swings and Analyst Narratives - Yahoo
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
All You Need to Know About Teladoc (TDOC) Rating Upgrade to Buy - sharewise.com
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength? - Nasdaq
Rising Trends of Mental Health Systems Market Generated Opportunities, Future Scope 2025-2032 - openPR.com
Is Teladoc Health Inc a good long term investmentSupport Zone Identification & High Return Trading Ideas - earlytimes.in
Is Teladoc Health Inc. stock a good hedge against inflationQuarterly Trade Review & High Conviction Buy Zone Alerts - newser.com
Teladoc Health Inc. stock trend forecastWeekly Trend Report & Fast Gain Stock Tips - newser.com
Analyzing drawdowns of Teladoc Health Inc. with statistical toolsTrade Volume Report & Safe Entry Zone Identification - newser.com
Teladoc Health (TDOC): Assessing Valuation After New Catalysts Lift Market Sentiment - Sahm
Real time scanner hits for Teladoc Health Inc. explainedPortfolio Return Summary & Detailed Earnings Play Alerts - newser.com
How to track smart money flows in Teladoc Health Inc.July 2025 Selloffs & Real-Time Volume Analysis - newser.com
Farther Finance Advisors LLC Acquires 8,061 Shares of Teladoc Health, Inc. $TDOC - Defense World
Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Teladoc Health Inc. (TDOC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Why Teladoc Health Stock Jumped 15% This Morning - sharewise.com
Teladoc Health’s Surprising Spike: What’s Driving It Today? - StocksToTrade
Teladoc Health’s Recent Developments: Analysis - timothysykes.com
Why Teladoc (TDOC) Stock Is Moving Today - GuruFocus
Teladoc (TDOC) Shares Climb On Bullish Commentary From Citron Research - inkl
Teladoc stock surges after Citron Research highlights positive metrics - Investing.com
Can Teladoc (TDOC) Offset Regulatory Uncertainty With Diversification Into Insurance-Based Mental Health? - Sahm
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Teladoc Health Inc-Aktie (TDOC) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 11 '25 |
Sale |
7.59 |
16,787 |
127,435 |
179,014 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):